AACC 2019

71st AACC Annual Scientific Meeting & Clinical Lab Expo

Aug. 4–8, 2019 | Anaheim, CA | Booth 3201

Explore the latest innovations in laboratory medicine at AACC 2019 in Anaheim, CA.

Stay informed. Sign up to receive news and alerts for AACC 2019.

 Sign up

Elevate your performance. Advance patient care.


Join us at the AACC laboratory medicine conference, taking place this year in Orange County, California, a community that we and our local associates have been privileged to serve for over 80 years. Stop by booth 3201 at the Anaheim Convention Center to network with clinical laboratory peers and hear from scientific experts. Learn about cutting-edge advancements in clinical chemistry, hematology, clinical information management tools and more.  

Bring the benefit of automation for all

Automation isn’t just for ultra high-volume laboratories. Check out our configurations for low-, mid- and high-volume laboratories in the booth.
  • Coming soon: Get an in-depth view of how the innovative DxA 5000* total laboratory automation system helps deliver unparalleled rapid and consistent turnaround times, provides a new level of comprehensive preanalytical sample quality detection and significantly reduces the number of manual processing steps to improve laboratory efficiency
  • See how the modular open platform of the Copan WASP® DT: Walkaway Specimen Processor adapts to the changing needs of your clinical microbiology laboratory. Find out how you can automate all core aspects of microbiology specimen processing, including plating and streaking, gram-stain slide preparation and enrichment broth inoculation

Deliver greater insights through clinical informatics

Identify ways to save time, increase productivity and deliver greater insights with the DxONE clinical informatics portfolio, featuring:

Accelerate care with a menu that matters

Learn how laboratories can empower clinical staff in identifying prevalent and costly health risks sooner with solutions such as:

Have questions regarding our menu? Contact your Beckman Coulter sales representative to schedule time with a scientific expert.

Unlock the hidden value through performance partnership

Discover how your peers are saving costs, improving efficiency and preparing their laboratories for the future with Danaher Business System workflow consultation.

Stay up to date: Sign up  to receive news and alerts as well as Beckman Coulter scientific posters from AACC. 

Sign up

We look forward to seeing you in Anaheim.

A Race against Time –— the Challenge of Sepsis for Clinicians and Laboratorians

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection. It is estimated that this condition affects approximately 30 million people worldwide every year and carries a 25–-30% mortality rate. Sepsis is also costly to healthcare organizations, with more than $24 billion dollars spent on it annually in the United States alone.

Early detection and diagnosis are key to stopping the progression of sepsis. Join us for this educational event at the 71st AACC Annual Scientific Meeting to hear from a panel of experts about the diagnosis and treatment of this deadly condition.

Attendees will learn to: 
  • Describe the healthcare burden of sepsis
  • Summarize the clinical guidelines used in establishing a sepsis protocol
  • Discuss the roles of the various stakeholders in the diagnosis and management of sepsis
  • Discuss sepsis biomarkers and antibiotic stewardship

Register for sepsis conference ›


Time Topic Speaker

Tuesday, August 6
7:00 –8:30 a.m.
Hilton Anaheim,
Pacific AB Room

 A Race against Time – the Challenge of Sepsis for Clinicians and Laboratorians Jeannine Holden, M.D., (moderator)
Chief Medical Officer and Vice President, Medical and Scientific Affairs
Beckman Coulter, Inc., Brea, CA

  • Sepsis clinical presentation, current challenges in clinical assessment
  • Current sepsis protocol
  • Emerging diagnostic technology (the Early Sepsis Indicator)
David Huang, M.D., M.P.H. (clinician perspective) 
Associate Professor of Critical Care Medicine and Emergency Medicine
Department of Critical Care Medicine
University of Pittsburgh School of Medicine 

  • How the lab supports the sepsis protocol in your medical institution 
  • Key elements/components for managing the protocol
  • Lab tests to support sepsis management (lactate, procalcitonin, etc.)
Octavia Peck-Palmer, Ph.D. (laboratorian perspective)
Associate Professor, Departments of Pathology, Critical Care Medicine, and Clinical and Translational Science, University of Pittsburgh School of Medicine 
Medical Director, Automated Testing Laboratories, UPMC Presbyterian, Shadyside, and Children's Hospital of Pittsburgh, PA

Sepsis and antibiotic stewardship Barbara Zimmer, Ph.D. (antibiotic stewardship and sepsis)
Principal Scientist, Scientific Affairs
Beckman Coulter, Inc., Brea, CA


Joint Industry-sponsored Workshop developed in partnership with AACC:

The Fourth Universal Definition of Myocardial Infarction (MI) in Conjunction with the Clinical Laboratory Practice Recommendations for the Use of High-sensitivity Cardiac Troponin in Acute Coronary Syndrome

Includes interactive panel discussion led by experts from the IFCC Committee on Clinical Applications of Cardiac Biomarkers.

Fred S. Apple, Ph.D., D.A.B.C.C., F.A.C.S.M.
Alan Jaffe, M.D.
Richard Body, M.B. Ch.B, M.R.C.S.Ed. (A&E), F.R.C.E.M., Ph.D.
Peter Kavsak, Ph.D., F.C.A.C.B., F.A.A.C.C., F.C.C.S.

Paul Collinson, M.D.
Amy Saenger, Ph.D., D.A.B.C.C. 
Alan Wu, Ph.D., D.A.B.C.C.
Martin Than, M.D.

Wednesday, August 7, 2019
7:00–8:30 a.m.

Hilton Anaheim: California Ballrooms C/D

Consensus recommendations with the Fourth Universal Definition of Myocardial Infarction guidelines reinforce guidance on the use of high-sensitivity cardiac troponin assays published by the AACC Academy Laboratory Medicine Practice group and IFCC Committee on Clinical Applications of Biomarkers. This workshop provides cross-discipline (laboratory, emergency medicine, cardiology) commentary with evidence-based rule-out, diagnostic and risk assessment clinical studies addressing: QC utilization, reportable analytical limits, units for reporting, sex-specific 99th percentiles, defining high-sensitivity assays, preanalytic/analytic challenges, harmonizing assays, turnaround times, and biological variabilities in interpreting serial (delta) collections. A multidisciplinary expert panel will address audience questions.

Expected Outcomes

1. Understand the laboratory medicine expert recommendations* along with the Fourth Universal Definition of Myocardial Infarction** for the use of high-sensitivity cardiac troponin in acute coronary syndromes including impact to emergency medicine, cardiology and laboratory medicine. 

2. Become educated on the analytical characteristics unique to high-sensitivity cardiac troponin assays, how they differ from contemporary and POC assays, as well as guidance on how to implement high-sensitivity cardiac troponin assays in clinical practice.

3. Explore clinical and analytical challenges encountered in daily practice by the laboratory, emergency medicine and cardiology following implementation with an interactive expert panel discussion and audience engagement.

A continental breakfast will be included

Register for MI workshop

* Wu AHB, Christenson RH, Greene DN, Jaffe AS, Kavsak PA, Ordonez-Llanos J, Apple FS. Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2018;64:545–655.

** Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Mickley H, Crea F, Van de Werf F, Bucciarelli-Ducci C, Katus HA, Pinto F, Antman EM, Hamm CW, De Caterina R, Januzzi J, Apple FS, Garcia AA, Underwood R, Canty J, Lyon A, Devereaux PJ, Jamorano JL, Lindahl B, Weintraub W, Newby LK, Virmani R, Vranckx R, Cutlip D, Gibbons R, Smith RC, Atar D, Luepker RW, Robertson RM, Bonow R, Steg P, O’Gara P, Fox KA. Fourth Universal Definition of Myocardial Infarction. J Amer Coll Cardiol. 2018:72:2231–2264.

1Sepsis Alliance. “Fact Sheet.2018.” Sepsis.org. Accessed 6 Mar. 2019.

2Torio C, Moore B. “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer.” www.hcup-us.ahrq.gov/reports/statbriefs/sb204-Most-Expensive-Hospital-Conditions.pdf, May 2016. Accessed 15 Jan. 2018.